drugset / Trial / NCT06189404

Effect of Tigulixostat on the Pharmacokinetics of Theophylline

NCT06189404

Phase 1 Completed 24 enrolled LG Chem
NaSingle-groupOpen-labelBasic science

Summary

A phase 1, open-label, drug-drug interaction study to evaluate the effect of multiple doses of tigulixostat on the pharmacokinetics of single-dose theophylline in healthy adult volunteers.

Timeline

Start
2023-10-31
Primary completion
2023-11-13
Completion
2023-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Theophylline Small molecule 400 mg Oral
Subject Tigulixostat Small molecule 300 mg Oral

Indications